Final Program in it's entirety - MyGirlsBlood

Posters, Tuesday and Wednesday
Index of Poster Presenters cont’d
35P44
Therapeutic Algorithm for Patients with Acquired von
Willebrand Syndrome and Monoclonal Gammopathy
Staritz P1 , Krause M2 , Zimmermann R1 , Huth-Kühne A1 1SRH Kurpfalzkrankenhaus, Hemophilia Care Center,
Heidelberg, Germany 2Deutsche Klinik für Diagnostik,
Fachbereich Hämostaseologie, Wiesbaden, Germany
35P45
Review of 5 Cases with an Acquired von Willebrand
Syndrome
Suzuki T, Amano K, Otaki M, Tsujikawa A, Inaba H,
Fukutake K
Dept. of Laboratory Medicine, Tokyo Medical University,
Tokyo, Japan
35P46
Functional Characterization of a Recombinant von Willebrand
Factor (VWF) Drug Candidate
Schrenk G, Rottensteiner H, Varadi K, Ehrlich HJ, Schwarz
HP, Turecek P
Baxter Innovations GmbH, Vienna, Austria
35P47
Structural Characterization of Recombinant Human von
Willebrand Factor (rVWF) Produced on Large Scale
Graninger M, Foettinger-Vacha A, Kaliwoda M, Purtscher M,
Mitterer A, Turecek P
Baxter Innovations GmbH, Vienna, Austria
35P48
Interaction Studies of Recombinant VWF (rVWF) and
Recombinant FVIII (rFVIII) in Solution
Schrenk G, Rottensteiner H, Turecek P, Ehrlich HJ, Schwarz
H-P, Varadi K
Baxter Innovations GmbH, Vienna, Austria
35P49
The Kinetics of Recombinant VWF Cleavage by Human
ADAMTS13 is Similar to that of Plasma-Derived VWF
Rottensteiner H, Vejda S, Schreiner J, Gritsch H, Turecek PL,
Varadi K
Baxter Innovations GmbH, Vienna, Austria
35P50
Acquired von Willebrand Syndrome Associated with a
Monoclonal Gammopathy: Experience of a Single-Centre
Registry in 36 Patients
Voisin S1 , Hamidou M2 , Lefrançois A3 , Sigaud M3 , Mahé B4 ,
Trossaërt M3 1 2 Laboratoire Hématologie Hôpital Toulouse France, Service
de Médecine Interne Hôpital Nantes France, 3Laboratoire Hématologie Hôpital Nantes France, 4Service d’Hématologie
Clinique Hôpital Nantes France
92
35P51
Successful Management of Cardiac Surgery with
Cardiopulmonary Bypass in an Acquired von Willebrand
Disease Patient
Volot F 1 , Dutrillaux F 1 , Bouchot O 2 , Leguy v 3 , De Maistre E 1 ,
Lorenzini J 1
1 Bocage Service Hématologie, 2 Cardiovascular Surgery and
3 Medicine, CRTH- CHU, Dijon, France
35P52
C1272f: A Novel Type 2a von Willebrand Disease Mutation
in A1 Domain
Woods A1 , Sanchez-Luceros A1, 2 , Kempfer A1 , Powazniak
Y3 , Calderazzo Pereyra J1 , Blanco A2 1National Council of Scientific and Technological Research
(CONICET), 2Hematological Research Institute, National
Academy of Medicine, 3SECYT, Buenos Aires, Argentina
35P53
Major Hemorrhage Related to Surgery in Patients with Type
2a von Willebrand Disease
Woods A1 , Meschengieser S2 , Sanchez-Luceros A1, 2 , Blanco
A2 , Kempfer A1 , Lazzari M1, 2
1National Council of Scientific and Technological Research
(CONICET), 2Hematological Research Institute, National
Academy of Medicine, Buenos Aires, Argentina
35P54
Alloantibodies in Type 3 VWD: Report of Two Cases and
Review of the Literature
Yaish H, Rodgers G
Primary Children Medical Center, University of Utah, Salt
Lake City, UT, U.S.A.
35P55
Northern Pakistan Experience of Severe von Willebrand
Disease
Zafar T1, 2 , Rizwi F1 , Winter M3 1Islamabad Medical & Dental College, Islamabad, Pakistan,
2 Pakistan Haemophilia Patients Welfare Society, Islamabad,
Pakistan, 3Kent Haemophilia Treatment Centre, Canterbury,
Kent, U.K.